PestleMedicine Explained

Tacrolimus

Tacrolimus 0.03% ointment is an immunomodulating medicine used to treat moderate to severe atopic dermatitis (eczema) in adults who do not respond well to, or cannot use, conventional treatments such as topical corticosteroids, and in children aged 2 years and over who have not responded well to them. It can also be used twice weekly to help prevent flares coming back in people with frequent flares.

Active ingredient: tacrolimus monohydrate

Official leaflet

Key facts

  1. It is used to treat moderate to severe eczema (atopic dermatitis) and works by calming the skin's over-reactive immune response, which relieves inflammation and itch.
  2. Apply a thin layer to affected skin only. Do not apply it to infected skin, and do not cover the treated skin with bandages or wraps.
  3. Avoid long periods in sunlight and tanning beds. Use sunscreen and wear loose clothing that protects the skin if you are outdoors after applying it.
  4. It is not approved for children younger than 2 years.
  5. Discard open tubes 180 days after opening, even if they are not empty.

Who should not take tacrolimus

The leaflet says not to take it if any of these apply to you.

  • If you are allergic to tacrolimus or any of the other ingredients of this medicine
  • If you are allergic to macrolide antibiotics (e.g. azithromycin, clarithromycin, erythromycin)

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • If you have liver failure
  • If you have any skin malignancies (tumours) or a weakened immune system (immuno-compromised), whatever the cause
  • If you have an inherited skin barrier disease such as Netherton's syndrome or lamellar ichthyosis
  • If you have an inflammatory skin disease such as pyoderma gangrenosum, or generalised erythroderma
  • If you have cutaneous Graft Versus Host Disease
  • If you have swollen lymph nodes at the start of treatment, or they become swollen during treatment (consult your doctor)
Show 9 moreShow fewer
  • If you have infected lesions (do not apply the ointment to infected lesions)
  • Tell your doctor if you notice any change to the appearance of your skin
  • Avoid long periods of sunlight or artificial sunlight such as tanning beds, and use sunscreen and protective clothing
  • Tell your doctor you are using it if you are prescribed light therapy, as using both at the same time is not recommended
  • If using it twice weekly to keep eczema cleared, your doctor should review your condition at least every 12 months; in children, maintenance treatment should be suspended after 12 months to assess whether it is still needed
  • Use the lowest strength, lowest frequency and shortest duration necessary, based on your doctor's assessment
  • Not approved for children younger than 2 years; its effect on the developing immune system in children has not been established
  • Drinking alcohol while using it may cause the skin or face to become flushed or red and feel hot
  • Contains butylated hydroxytoluene (E321), which may cause local skin reactions (e.g. contact dermatitis) or irritation to the eyes and mucous membranes

How to take tacrolimus

  • Apply a thin layer to affected areas of skin. It may be used on most parts of the body, including the face, neck and creases of the elbows and knees. Avoid the nose, mouth and eyes, and wipe or rinse it off with water if it gets there.
  • Children aged 2 years and over: use the 0.03% ointment twice a day (morning and evening) for up to three weeks, then once a day on each affected area until the eczema has gone.
  • Adults aged 16 years and over: your doctor will decide the strength (0.03% or 0.1%). Treatment usually starts with the 0.1% ointment twice a day until the eczema has cleared.
  • Do not cover treated skin with bandages or wraps. Make sure skin is completely dry after a bath or shower, and wash your hands after applying unless they are also being treated.
  • If your doctor tells you to use it twice weekly once eczema has cleared or almost cleared, apply it once a day on two days a week (e.g. Monday and Thursday), with 2 to 3 days between applications. If you forget a dose, apply it as soon as you remember and then continue as before.

Side effects

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Very common

More than 1 in 10 people

  • burning sensation
  • itching

Common

Up to 1 in 10 people

  • redness
  • feeling of warmth
  • pain
  • increased skin sensitivity (especially to hot and cold)
  • skin tingling
  • rash
  • local skin infection regardless of specific cause
  • inflamed or infected hair follicles
  • cold sores
  • generalised herpes simplex infections
Show 1 moreShow fewer
  • facial flushing or skin irritation after drinking alcohol

Uncommon

Up to 1 in 100 people

  • acne

Not stated

The leaflet gives no frequency

  • application site infections following twice-weekly treatment (reported in children and adults)
  • impetigo (reported in children)
  • rosacea (facial redness)
  • rosacea-like dermatitis
  • lentigo (flat brown spots on the skin)
  • oedema at the application site
  • herpes eye infections

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. The leaflet gives no further information.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Any other medicines you are using, have recently used or might use
  • Other preparations used on the skin
  • Oral corticosteroids (e.g. cortisone)
  • Medicines which affect the immune system
  • Moisturising creams and lotions (can be used during treatment but not within two hours of applying the ointment)
  • Light therapy (inform your doctor if you are prescribed it)

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Tacrolimus 0.03% Ointment
Product licence
PL 20416/1015
Leaflet dated
Checked against the leaflet
Automated check
21 of 21 side effects matched to the wording of the leaflet

Other makers of tacrolimus publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.